January 3rd 2025
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Three-Dimensional Ultrasound Assessment of Endometrial Receptivity: a Review
June 14th 2011Three-dimensional ultrasound (3D US) is a new imaging modality, which is being introduced into clinical practice. Although this technique will not probably replace two-dimensional ultrasound, it is being increasingly used.
Read More
What Role Does Being Overweight Play in Endometrial Cancer?
April 18th 2011Endometrial cancer remains the most commonly diagnosed gynecologic cancer in the United States. In fact, the number of women affected by the disease continues to rise despite a slight decline in annual incidence rates in the past 30 years.
Read More
Use of Strategies to Reduce Risk of Opioid Misuse Is Low
April 8th 2011The use of opioid risk-reduction strategies by primary care physicians is limited, even among patients at particular risk of misuse, according to a study published online Feb. 24 in the Journal of General Internal Medicine.
Read More
Uterine Risk Factors Impact Endometrial Cancer Survival
April 4th 2011Uterine risk factors (RF) strongly influence survival of women with endometrial cancer, independent of nodal metastasis, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.
Read More
Q&A: Endometriosis and Breastfeeding
February 3rd 2011A 30 y/o woman, P1001, sought a second opinion from me regarding the following situation: She just had her first baby, and has a history of symptomatic endometriosis including some difficulty in achieving pregnancy (but did so without medical intervention). She was advised by another physician that she should use either depo or the progestin only pill for the next 6-12 months (while she is breastfeeding) to prevent the progression of endometriosis.
Read More
Laser Capture Microdissection and cDNA Array Analysis of Endometrium Identify CCL16 and CCL21
May 18th 2007Understanding the pathophysiology of chemokine secretion in endometriosis may offer a novel area of therapeutic intervention. This study aimed to identify chemokines differentially expressed in epithelial glands in eutopic endometrium from normal women and those with endometriosis, and to establish the expression profiles of key chemokines in endometriotic lesions.
Read More